Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement equity awards to fifteen newly hired non-executive employees. The awards were made as an inducement material to each recipient’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).
Covered in this story
What has happened since
- Ocular Therapeutix Inc is down 12.3% since this was published, 13 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $OCUL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ocular Therapeutix Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.